Randomized, Open-Label, Phase IV Trial in Nucleos(t)ide-Naive Patients With Chronic Hepatitis B to Examine the Effect of Telbivudine Compared to Lamivudine on the Early Dynamics and Kinetics of Viral Suppression (Early-Viral-Dynamics Study).
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 01 May 2009
At a glance
- Drugs Lamivudine; Telbivudine
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms EVD
- 01 May 2009 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 15 Jul 2008 New trial record.